<DOC>
	<DOCNO>NCT01155882</DOCNO>
	<brief_summary>The purpose study determine effective Whipple Splenic Artery ( WATSA ) .</brief_summary>
	<brief_title>Registry Study - Whipple Splenic Artery</brief_title>
	<detailed_description>Primary The primary objective registry study collect clinical data patient undergo WATSA procedure . Specific hypothesis test - To determine effective Whipple Splenic Artery ( WATSA ) resect tumor negative microscopic margin ( R0 ) resection line pancreas tangential posterior , uncinate , venous margin . - To determine WATSA perform within usual range morbidity mortality ( 30 day postoperative mortality ) standard Whipple procedure . Secondary The secondary objective registry study - To determine survival/recurrence rate 2 year . - To determine effect occlusion splenic vein confluence .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Eligibility Criteria Prospective Portion : Patient must diagnosis ductal adenocarcinoma head and/or neck pancreas , ampullary adenocarcinoma , pancreatic neuroendocrine tumor confirm tissue diagnosis . Patient must 18 85 year age . Patient must candidate WATSA procedure WATSA surgery perform within 1 year . Patient must able understand willing sign write informed consent document . Eligibility Criteria Retrospective Portion : Patient underwent WATSA procedure institution 01/01/2009 12/31/2011 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>